| Literature DB >> 21561830 |
Yan Li1, Ji-an Chen, Qing Zhao, Chaowen Pu, Zhiqun Qiu, Renping Zhang, Weiqun Shu.
Abstract
BACKGROUND: Microcystin-producing Microcystis bloom is a severe water problem in the world. Some reports indicate that chronic exposure to microcystin may result in liver damage in adults, but information on effects in children is limited.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21561830 PMCID: PMC3230426 DOI: 10.1289/ehp.1002412
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
MC-LR levels in three water sources in the Three Gorges Reservoir Region.
| Well water | Lake 1 water | Lake 2 water | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Mean ± SD | Range | Mean ± SD | Range | Mean ± SD | Range | ||||||||||||
| 2005 | 4 | — | < LOD | 4 | 0.2 ± 0.2 | 0.1–0.5 | 4 | 1.1 ± 0.3 | 0.8–1.5 | |||||||||
| 2006 | 6 | — | < LOD | 3 | 0.1 ± 0.2 | < LOD–0.3 | 3 | 3.2 ± 1.7 | 1.8–5.1 | |||||||||
| 2007 | 4 | — | < LOD | 4 | 0.4 ± 0.3 | 0.2–0.8 | 4 | 4.1 ± 1.6 | 2.3–6.1 | |||||||||
| 2008 | 8 | 0.1 ± 0.1 | < LOD–0.2 | 4 | 0.3 ± 0.2 | 0.1–0.6 | 4 | 4.3 ± 1.0 | 3.5–5.7 | |||||||||
| 2009 | 5 | — | < LOD | 5 | 0.2 ± 0.2 | 0.1–0.5 | 5 | 0.2 ± 0.1 | 0.1–0.4 | |||||||||
| 2009 | 5 | — | < LOD | 5 | 0.3 ± 0.2 | 0.1–0.6 | 5 | 0.4 ± 0.2 | 0.3–0.7 | |||||||||
| Average | — | 0.24 ± 0.11 | 2.58 ± 1.86 | |||||||||||||||
Figure 1(A) MC-LR concentrations in the liver of aquatic food from lake 1 and lake 2. (B) MC-LR concentrations in the muscle of aquatic food from lake 1 and lake 2. DW, dry weight. All samples were collected in August 2009.
General characteristics of the study population in the Three Gorges Reservoir Region.
| Parameter | Unexposed children | Low-exposed children | High-exposed children | |||||
|---|---|---|---|---|---|---|---|---|
| No. (%) | 145 (11) | 183 (14) | 994 (75) | – | ||||
| Male:female (%) | 52:48 | 54:46 | 51:49 | 0.75 | ||||
| Age (years) | 11.2 ± 1.8 | 10.3 ± 0.7 | 11.6 ± 2.5 | 0.03 | ||||
| HBV infection ( | 3 | 4 | 37 | 0.39 | ||||
| Hepatotoxic medicines used ( | 7 | 9 | 65 | 0.55 | ||||
| Consumption of water per child per day (L) | 1.1 ± 0.5 | 1.2 ± 0.6 | 1.1 ± 0.4 | 0.09 | ||||
| Strenuous exercise [yes:no ( | 18:127 | 28:155 | 162:832 | 0.48 | ||||
| BMI ( | 0.23 | |||||||
| < 16 | 39 | 49 | 288 | |||||
| 16–18 | 51 | 62 | 391 | |||||
| > 19 | 55 | 72 | 315 | |||||
| Frequency of aquatic food consumption ( | 0.39 | |||||||
| < 1 time/week | 12 | 11 | 81 | |||||
| 1–2 times/week | 73 | 89 | 487 | |||||
| 3–6 times/week | 47 | 65 | 367 | |||||
| > 6 times/week | 13 | 18 | 59 | |||||
| Smoking status ( | 0.001 | |||||||
| Nonpassive smoker | 102 | 116 | 878 | |||||
| Passive smoker | 42 | 67 | 110 | |||||
| Smoker | 1 | 0 | 8 | |||||
Estimated average total daily intakes of microcystin in exposed children in Three Gorges Reservoir Region.
| Exposure | Low exposed | High exposed | ||
|---|---|---|---|---|
| Through drinking water | ||||
| Microcystin concentration in water (mean) | 0.24 | 2.58 | ||
| Daily water intake/child (L) | 1.2 | 1.2 | ||
| Microcystin daily intake by drinking water/child (µg) | 0.14 | 1.55 | ||
| Through aquatic food | ||||
| Microcystin concentration in aquatic food (mean in lyophilized
muscle) | 0.10 | 0.22 | ||
| Daily aquatic food intake/child [dry (g)] | 2.2 | 2.2 | ||
| Microcystin daily intake by food/child (µg) | 0.22 | 0.48 | ||
| Total daily intake (drinking water + aquatic food)/child (µg) | 0.36 | 2.03 | ||
| WHO TDI of microcystin for 10-kg (BW) child (µg) | 0.4 | |||
| BW, body weight. | ||||
Risk factors for liver damagea as measured by serum enzyme levels in Three Gorges Reservoir Region.
| Variable | OR (95% CI) | ||||
|---|---|---|---|---|---|
| Microcystin exposed | 1.72 | (1.05– 2.76) | 0.03 | ||
| HBV-positive | 7.59 | (5.36–10.79) | 0.001 | ||
| Hepatotoxic medication use | 3.49 | (2.17–5.63) | 0.001 | ||
| BMI | |||||
| < 16 | 1.0 | — | — | ||
| 16–18 | 1.03 | (0.24–2.88) | 0.33 | ||
| > 18 | 1.02 | (0.22–2.65) | 0.39 | ||
| Strenuous exercise | 0.85 | (0.19–2.36) | 0.48 | ||
| Passive smoking exposure | 1.48 | (0.74–3.15) | 0.13 | ||
Serum liver damage enzyme levels in relationship with related risk factors in the three groups.
| Risk factor | Unexposed ( | Low exposed ( | High exposed ( | |||||
|---|---|---|---|---|---|---|---|---|
| HBV infected [ | 3 (2.1) | 4 (2.2) | 37 (3.7) | 0.39 | ||||
| Hepatotoxic medicines used [ | 7 (4.8) | 9 (4.9) | 65 (6.5) | 0.55 | ||||
| HBV-negative, no hepatotoxic medicine use [ | 135 (93.1) | 170 (92.9) | 892 (89.7) | 0.22 | ||||
| ALT (U/L) | 14.0 (12.6–15.4) | 16.1 (14.5–17.7) | 14.8 (14.2–15.4) | 0.14 | ||||
| AST (U/L) | 27.6 (26.2–29.0) | 30.3 (29.3–31.3) | 33.4 (32.8–34.0) | 0.01 | ||||
| GGT (U/L) | 14.8 (13.7–15.8) | 17.0 (16.2–17.8) | 16.2 (15.7–16.7) | 0.18 | ||||
| ALP (U/L) | 281.3 (269.5–293.1) | 285.6 (272.9–298.3) | 288.7 (281.4–296.0) | 0.00 | ||||
| Enzyme abnormalities [ | 6 (4.4) | 10 (5.9) | 96 (10.8) | 0.22 | ||||
Serum MC-LR levels according to exposure group.
| MC-LR detection | Unexposed | Low exposed | High exposed | |||||
|---|---|---|---|---|---|---|---|---|
| Serum samples detected ( | 54 | 57 | 62 | – | ||||
| MC-LR–positive [ | 1 (1.9) | 48 (84.2) | 57 (91.9) | 0.001 | ||||
| Mean (mean ± SD) | < LOD | 0.4 ± 0.1 | 1.3 ± 0.2 | 0.04 | ||||